CEBP http://www.cancermicroenvironment.tau.ac.il/welcome2009.html Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duncan, R. E.
Right arrow Articles by Archer, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duncan, R. E.
Right arrow Articles by Archer, M. C.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1897-1898, August 2005
© 2005 American Association for Cancer Research


Hypothesis/Commentary

Statins and Cancer Development

Robin E. Duncan, Ahmed El-Sohemy and Michael C. Archer

Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Requests for reprints: Michael C. Archer, Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, 150 College Street, Toronto, ON, Canada M5S 3E2. Phone: 416-978-8195; Fax: 416-971-971-2366. E-mail: m.archer{at}utoronto.ca

There is epidemiologic evidence that the hydrophilic 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor pravastatin increases the incidence of some extrahepatic cancers, although this finding has been attributed to chance. We hypothesize that pravastatin is able to promote the development of cancer by causing an induction of HMG-CoA reductase and, hence, mevalonate synthesis in extrahepatic tissues. We have shown that mevalonate, the product of HMG-CoA reductase, promotes the growth of breast cancer cells. Because there is no uptake of pravastatin by most extrahepatic cells, this statin will be unable to mitigate the increase in mevalonate synthesis in extrahepatic tissues that accompanies the decrease in circulating cholesterol caused by its inhibition of hepatic HMG-CoA reductase.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Villagra, N. Ulloa, X. Zhang, Z. Yuan, E. Sotomayor, and E. Seto
Histone Deacetylase 3 Down-regulates Cholesterol Synthesis through Repression of Lanosterol Synthase Gene Expression
J. Biol. Chem., December 7, 2007; 282(49): 35457 - 35470.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. D. Flick, L. A. Habel, K. A. Chan, S. K. Van Den Eeden, V. P. Quinn, R. Haque, E. J. Orav, J. D. Seeger, M. C. Sadler, C. P. Quesenberry Jr., et al.
Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2218 - 2225.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Haydont, C. Bourgier, M. Pocard, A. Lusinchi, J. Aigueperse, D. Mathe, J. Bourhis, and M.-C. Vozenin-Brotons
Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats
Clin. Cancer Res., September 15, 2007; 13(18): 5331 - 5340.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. A. Hall, S. T. Page, T. G. Travison, R. B. Montgomery, C. L. Link, and J. B. McKinlay
Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1587 - 1594.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. M. Boudreau, O. Yu, D. L. Miglioretti, D. S.M. Buist, S. R. Heckbert, and J. R. Daling
Statin Use and Breast Cancer Risk in a Large Population-Based Setting
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 416 - 421.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
S. Bonovas and N. M. Sitaras
Does pravastatin promote cancer in elderly patients? A meta-analysis
Can. Med. Assoc. J., February 27, 2007; 176(5): 649 - 654.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. Belay, P. F. Belamarich, and C. Tom-Revzon
The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
Pediatrics, February 1, 2007; 119(2): 370 - 380.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. E. Duncan, A. El-Sohemy, and M. C. Archer
Statins and the Risk of Cancer
JAMA, June 21, 2006; 295(23): 2720 - 2720.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. A. Cauley, A. McTiernan, R. J. Rodabough, A. LaCroix, D. C. Bauer, K. L. Margolis, E. D. Paskett, M. Z. Vitolins, C. D. Furberg, and R. T. Chlebowski
Statin use and breast cancer: prospective results from the Women's Health Initiative.
J Natl Cancer Inst, May 17, 2006; 98(10): 700 - 707.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
J. E. Celis, P. Gromov, J. M. A. Moreira, T. Cabezon, E. Friis, I. M. M. Vejborg, G. Proess, F. Rank, and I. Gromova
Apocrine Cysts of the Breast: Biomarkers, Origin, Enlargement, and Relation with Cancer Phenotype
Mol. Cell. Proteomics, March 1, 2006; 5(3): 462 - 483.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.